UF startup and UF Innovate | Sid Martin Biotech resident client entrinsic bioscience (EBS), a company pioneering a next-generation protein modulation technology, announced that it has been granted U.S. Patent No. (USPN) 10,758,507 (‘507 patent) for novel therapeutic formulations in the treatment of a range of respiratory diseases with significant unmet medical needs. EBS is … Continue reading entrinsic bioscience Secures U.S. Patent Grant for Breakthrough Respiratory Disease Program